These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17517836)

  • 61. Fluoroquinolone resistance and Clostridium difficile, Germany.
    Zaiss NH; Witte W; Nübel U
    Emerg Infect Dis; 2010 Apr; 16(4):675-7. PubMed ID: 20350385
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013.
    Tickler IA; Goering RV; Whitmore JD; Lynn AN; Persing DH; Tenover FC;
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4214-8. PubMed ID: 24752264
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.
    Lew T; Putsathit P; Sohn KM; Wu Y; Ouchi K; Ishii Y; Tateda K; Riley TV; Collins DA
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32393487
    [No Abstract]   [Full Text] [Related]  

  • 64. Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.
    Garneau JR; Valiquette L; Fortier LC
    BMC Infect Dis; 2014 Jan; 14():29. PubMed ID: 24422950
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden.
    Norén T; Alriksson I; Akerlund T; Burman LG; Unemo M
    Clin Microbiol Infect; 2010 Aug; 16(8):1104-10. PubMed ID: 19732094
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.
    Walkty A; Boyd DA; Gravel D; Hutchinson J; McGeer A; Moore D; Simor A; Suh K; Taylor G; Miller M; Mulvey MR;
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):419-24. PubMed ID: 20226332
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile.
    Farrell DJ; Putnam SD; Biedenbach DJ; Moro L; Bozzella R; Celasco G; Jones RN
    Antimicrob Agents Chemother; 2011 Mar; 55(3):992-6. PubMed ID: 21149623
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile.
    Aldape MJ; Heeney DD; Bryant AE; Stevens DL
    J Antimicrob Chemother; 2015 Jan; 70(1):153-9. PubMed ID: 25151204
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antimicrobial activities of fidaxomicin.
    Goldstein EJ; Babakhani F; Citron DM
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S143-8. PubMed ID: 22752863
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A US-based national surveillance study for the susceptibility and epidemiology of
    Snydman DR; McDermott LA; Thorpe CM; Goldstein EJC; Schuetz AN; Johnson S; Gerding DN; Gluck L; Bourdas D; Carroll KC; Lancaster CK; Garey KW; Wang Q; Walk ST; Duperchy E
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0034923. PubMed ID: 37728368
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.
    Carman RJ; Boone JH; Grover H; Wickham KN; Chen L
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6019-20. PubMed ID: 22908175
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
    Karlowsky JA; Adam HJ; Baxter MR; Dutka CW; Nichol KA; Laing NM; Golding GR; Zhanel GG
    J Antimicrob Chemother; 2020 Jul; 75(7):1824-1832. PubMed ID: 32294172
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile.
    Collins DA; Wu Y; Tateda K; Kim HJ; Vickers RJ; Riley TV
    J Antimicrob Chemother; 2021 Mar; 76(4):967-972. PubMed ID: 33351917
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
    Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
    Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High Prevalence of Multidrug-Resistant
    Mutai WC; Mureithi MW; Anzala O; Revathi G; Kullin B; Burugu M; Kyany'a C; Odoyo E; Otieno P; Musila L
    Front Cell Infect Microbiol; 2020; 10():604986. PubMed ID: 33628744
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital.
    Curry SR; Marsh JW; Shutt KA; Muto CA; O'Leary MM; Saul MI; Pasculle AW; Harrison LH
    Clin Infect Dis; 2009 Feb; 48(4):425-9. PubMed ID: 19140738
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.
    Ilchmann C; Zaiss NH; Speicher A; Christner M; Ackermann G; Rohde H
    Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1571-3. PubMed ID: 20632051
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Trends of Antimicrobial Susceptibility of
    Fang QQ; Zhang XX; Wang XH; Feng P; Zong ZY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):123-127. PubMed ID: 31037915
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.